Literature DB >> 25546154

Changes in serum iodine concentration, urinary iodine excretion and thyroid function after hysterosalpingography using an oil-soluble iodinated contrast medium (lipiodol).

Terumi Kaneshige1, Naoko Arata, Shohei Harada, Toshinori Ohashi, Shiori Sato, Nagayoshi Umehara, Takakazu Saito, Hidekazu Saito, Atsuko Murashima, Haruhiko Sago.   

Abstract

OBJECTIVE: Reports of hypothyroidism after hysterosalpingography (HSG) using lipiodol are emerging. The present study was designed to investigate the changes in serum iodine concentration (SIC), urinary iodine concentration/creatinine excretion (UI/Cr), and thyroid function before and after HSG using lipiodol.
METHODS: The prospective observation study included 22 infertile euthyroid women with no previous history of thyroid disease. All underwent HSG between April 2007 and August 2008 at our institution. We examined SIC, UI/Cr, and thyroid function before HSG, and at 4, 8, 12, and 24 weeks, and 9-12 months after HSG.
RESULTS: The median value of SIC and UI/Cr peaked at 4 weeks after HSG and remained at significantly high levels at 8, 12, and 24 weeks post-HSG compared with pre-HSG. In sync with the increase of iodine, the mean level of TSH significantly increased at 4, 8, 12, and 24 weeks post-HSG compared with pre-HSG. After 24 weeks, differences in SIC, UI/Cr, and TSH levels before and after HSG became nonsignificant. The mean value of free triiodothyronine and free thyroxine showed no significant difference at any of the time points compared with pre-HSG. Three cases (13.6%) showed transient high TSH (>5 μIU/L) with normal thyroid hormones at 4 or 8 weeks after HSG.
CONCLUSION: Thyroid monitoring should be conducted in the first 4-8 weeks after HSG using lipiodol and attention to thyroid dysfunction should be paid for up to 6 months after the procedure due to the possibility of excess iodine.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25546154     DOI: 10.1210/jc.2014-2731

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  10 in total

1.  Thyroid Dysfunction in Children Exposed to Iodinated Contrast Media.

Authors:  Meaghan L Barr; Harvey K Chiu; Ning Li; Michael W Yeh; Connie M Rhee; Jacqueline Casillas; Paul J Iskander; Angela M Leung
Journal:  J Clin Endocrinol Metab       Date:  2016-03-28       Impact factor: 5.958

2.  2021 European Thyroid Association Guidelines for the Management of Iodine-Based Contrast Media-Induced Thyroid Dysfunction.

Authors:  Tomasz Bednarczuk; Thomas H Brix; Wolfgang Schima; Georg Zettinig; George J Kahaly
Journal:  Eur Thyroid J       Date:  2021-06-16

Review 3.  Risk factors of subclinical hypothyroidism and the potential contribution to miscarriage: A review.

Authors:  Shuhei So; Fumiko Tawara
Journal:  Reprod Med Biol       Date:  2020-03-18

4.  The Impact of Preconceptional Hysterosalpingography with Oil-based Contrast on Maternal and Neonatal Iodine Status.

Authors:  Rongrong Li; Wei Chen; Yanping Liu; Liangkun Ma; Ling Qiu; Jianhua Han; Rui Li
Journal:  Reprod Sci       Date:  2021-06-02       Impact factor: 3.060

Review 5.  Radiographic and magnetic resonances contrast agents: Essentials and tips for safe practices.

Authors:  Mohamed R Nouh; Mohamed A El-Shazly
Journal:  World J Radiol       Date:  2017-09-28

6.  Thyroid function in neonates conceived after hysterosalpingography with iodinated contrast.

Authors:  N van Welie; I Roest; M Portela; J van Rijswijk; C Koks; C B Lambalk; K Dreyer; B W J Mol; M J J Finken; V Mijatovic
Journal:  Hum Reprod       Date:  2020-05-01       Impact factor: 6.918

7.  Live birth after additional tubal flushing with oil-based contrast versus no additional flushing: a randomised, multicentre, parallel-group pragmatic trial in infertile women with at least one patent tube at hysterosalpingo-foam sonography (HYFOIL study).

Authors:  Diane De Neubourg; Lara Janssens; Iris Verhaegen; Elke Smits; Ben W Mol; Ella Roelant
Journal:  BMJ Open       Date:  2021-11-29       Impact factor: 2.692

8.  Hysterosalpingography with Oil-Soluble Contrast Medium Does Not Increase Newborn Hypothyroidism.

Authors:  Divya M Mathews; Jane M Peart; Neil P Johnson; Robert G Sim; Natasha L Heather; Dianne Webster; Susannah O'Sullivan; Paul L Hofman
Journal:  Int J Endocrinol       Date:  2022-02-22       Impact factor: 3.257

9.  Complications after hysterosalpingography with oil- or water-based contrast: results of a nationwide survey.

Authors:  Inez Roest; Nienke van Welie; Velja Mijatovic; Kim Dreyer; Marlies Bongers; Carolien Koks; Ben Willem Mol
Journal:  Hum Reprod Open       Date:  2020-01-15

10.  Effects of oil-soluble versus water-soluble contrast media at hysterosalpingography on pregnancy outcomes in women with a low risk of tubal disease: study protocol for a randomised controlled trial.

Authors:  Guiling Liang; Qian Zhu; Xiaoqing He; Xiaofeng Wang; Ling Jiang; Chenfeng Zhu; Li Xie; Zhaoxia Qian; Jian Zhang
Journal:  BMJ Open       Date:  2020-10-27       Impact factor: 2.692

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.